Evaluation of Stat5 as a potential drug target in bcr/abl-induced leukemias
نویسندگان
چکیده
Address: 1Centre of Biomolecular Medicine and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria, 2Institute of Molecular Pathology (IMP), 1030 Vienna, Austria, 3Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), 1090 Vienna, Austria, 4NIDDK, National Institute of Health, Bethesda, MD 20892, USA and 5Ludwig-Boltzmann Institute for Cancer Research (LBI-CR), 1090 Vienna, Austria
منابع مشابه
Bcr-abl Silencing by Specific Small-Interference RNA Expression Vector as a Potential Treatment for Chronic Myeloid Leukemia
Background: RNA interference (RNAi) is the mechanism of gene silencing-mediated messenger RNA degradation by small interference RNA (siRNA), which becomes a powerful tool for in vivo research, especially in the areas of cancer. In this research, the potential use of an expression vector as a specific siRNA producing tool for silencing of Bcr-abl in K562 cell line has been investigated. Methods:...
متن کاملEvaluation of the Effect of Curcumin and Imatinib on BCR-ABL Expression Gene in Chronic Human k562 Cells
Background and Aims: Detection of overexpression in tumor-inhibiting genes provides valuable information for leukemia diagnosis and prognosis. Chronic myeloid leukemia (CML) is a stem cell disorder determined by a well-defined genetic anomaly involving BCR-ABL translocation in the Philadelphia chromosome. Curcumin is a chemo-preventive agent for the primary cancer targets, such as the breast, p...
متن کاملStat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells
Signal transducers and activators of transcription (Stats) play central roles in the conversion of extracellular signals, e.g., cytokines, hormones and growth factors, into tissue and cell type specific gene expression patterns. In normal cells, their signaling potential is strictly limited in extent and duration. The persistent activation of Stat3 or Stat5 is found in many human tumor cells an...
متن کاملSTAT5 as a CML target: STATinib therapies?
BCR-ABL activate many signaling pathways in leukemic cells, such as RAS, PI-3K and NFB. STAT5 was one of the first pathways to be described as being constitutively activated by p210 BCR-ABL and p190 BCR-ABL.3-5 STAT5 activation has been shown to be correlated with functional effects such as antiapoptosis through activation of Bcl-XL6 and drug resistance phenotype through activation of Rad51.7 B...
متن کاملStat5 is indispensable for the maintenance of bcr/abl-positive leukaemia
Tumourigenesis caused by the Bcr/Abl oncoprotein is a multi-step process proceeding from initial to tumour-maintaining events and finally results in a complex tumour-supporting network. A key to successful cancer therapy is the identification of critical functional nodes in an oncogenic network required for disease maintenance. So far, the transcription factors Stat3 and Stat5a/b have been impl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 8 شماره
صفحات -
تاریخ انتشار 2008